Skip to main content

Breast Cancer Research

Ausgabe 1/2000

Inhalt (60 Artikel)

Commentary

The mammary myoepithelial cell - Cinderella or ugly sister?

Sunil R Lakhani, Michael J O'Hare

Commentary

Syk: a new player in the field of breast cancer

Zoe A Stewart, Jennifer A Pietenpol

Commentary

Whither high-dose chemotherapy in breast cancer?

Astrid Mayer, Helena Earl

Review

Imaging biochemistry: applications to breast cancer

Sabrina M Ronen, Martin O Leach

Meeting report

VIII International Congress of the Metastasis Research Society

Gill Taylor, Philip Rudland

Open Access Research article

BRCA1 and BRCA2 protein expressions in an ovotestis of a 46, XX true hermaphrodite

Dominique J Bernard-Gallon, Pierre Déchelotte, Cécile Vissac, Bénédicte Aunoble, Laetitia Cravello, Georges Malpuech, Yves-Jean Bignon

Open Access Research article

Transforming growth factors-β are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system

JoAnne Zujewski, Anika Vaughn-Cooke, Kathleen C Flanders, Michael A Eckhaus, Ronald A Lubet, Lalage M Wakefield

Paper Report

Microdissection and microarrays

Mike Davies

Paper Report

Estrogen receptor β in breast cancer

Balvinder Shoker

Paper Report

Chromosome 6 alterations

Chris Jones

Paper Report

ER variants in breast cancer

Valerie Speirs

Paper Report

Ang1 in breast cancer

Valerie Speirs

Paper Report

An anti-oncogenic role for decorin

Karen Schmeichel

Paper Report

Tissue microarray validation

Valerie Speirs

Paper Report

Endocrine response: Is CGAthe key?

Valerie Speirs

Paper Report

Carbonic anhydrase expression in DCIS

Rodolfo Laucirica

Paper Report

Duration of adjuvant tamoxifen treatment

Fatima Cardoso

Paper Report

Tamoxifen and angiogenesis

Valerie Speirs

Paper Report

Activin can activate p38 MAPK

Elena Neumann

Paper Report

GW5638: a new antiestrogen

Fatima Cardoso

Paper Report

Membrane oestrogen receptor

Valerie Speirs

Paper Report

EGF receptor: new trick for an old dog?

Douglas Yee

Paper Report

Dual HER-2/EGFR tyrosine kinase inhibitors

Fatima Cardoso

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.